Navigation Links
Data for Investigational Tiotropium Show Improved Lung Function and Sustained Bronchodilation in Patients with Moderate Asthma Severity
Date:9/10/2013

rol 50 mcg

123 mL
(P < 0.0001)

106 mL
(P < 0.0001)

114 mL
(P < 0.0001)To characterize the treatment response as greater than or equal to 0.5, measured by the ACQ, treatment with tiotropium (either 2.5 mcg or 5 mcg) resulted in a statistically significant improvement in the ACQ responder rate at 24 weeks compared with placebo and comparable to that of salmeterol. ACQ responder rates, performed on the pooled MezzoTinA-asthma results, were as follows:

  • Placebo: 57.7 percent (n=299/518)
  • Tiotropium 2.5 mcg once daily: 64.5 percent (n=332/515; P = 0.03)
  • Tiotropium 5 mcg once daily: 64.3 percent (n=330/513; P = 0.03)
  • Salmeterol 50 mcg twice daily: 66.5 percent (n=356/535; P = 0.004)
  • Patients in the MezzoTinA-asthma® studies were permitted to receive additional background therapy, including antihistamines, nasal steroids and leukotriene modifiers. Long-acting beta agonists (LABAs) were not permitted during the study (salmeterol was included as an active comparator for the trial).

    Adverse events were balanced across the four treatment groups groups in the pooled analysis with 58.2 percent of patients receiving tiotropium 2.5 mcg once daily reporting an adverse event compared to 57.3 percent of patients in the tiotropium 5 mcg once daily group, 54.3 percent of patients who received salmeterol 50 mcg twice daily and 59.1 percent of patients receiving placebo. The most commonly reported adverse events* were asthma, peak expiratory flow (PEF) rate decreased, nasopharyngitis and upper respiratory tract infection.

    About the UniTinA-Asthma® Clinical Trial Program
    The MezzoTinA-asthma® studies are a part of the comprehensive Phase 3 trial program, UniTinA-asthma®, which includes a number of clinical trials in adults, adolescents and pediatric patients across dif
    '/>"/>

    SOURCE Boehringer Ingelheim
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7

    Related medicine technology :

    1. Takedas New Investigational Drug Vedolizumab is Granted Priority Review Status by U.S. Food and Drug Administration for Ulcerative Colitis
    2. Data Published in the New England Journal of Medicine for Vedolizumab, an Investigational New Drug from Takeda for Moderately to Severely Active Ulcerative Colitis and Crohns Disease
    3. FDA Grants Orphan Drug Status To Eisais Investigational Compound (E7777) For Cutaneous T-Cell Lymphoma
    4. New Data for Abbotts Investigational High Sensitive Troponin Test Shows It May Help Doctors Predict Heart Attack Risk
    5. Grifols Implements Its First Automated Inventory Management Carousel System for Investigational Pharmacies at Emory University
    6. Signum Dermalogix Investigational New Drug (IND) Application Cleared by FDA: SIG990 a Potential Treatment for Rosacea
    7. Sanofi Announces Positive Phase 3 Results for Investigational New Insulin U300
    8. Phase III study finds investigational agent empagliflozin significantly reduced blood glucose in adults with type 2 diabetes and impaired kidney function
    9. Phase III data show investigational compound empagliflozin significantly reduced blood glucose in adults with type 2 diabetes
    10. Follow-up Phase II Data Analysis Adds to Body of Evidence for Investigational Novel Basal Insulin, LY2605541
    11. Phase III data show significant reduction in blood glucose with investigational compound empagliflozin added to metformin or metformin plus sulfonylurea in adults with type 2 diabetes
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:1/15/2014)... RAPIDS, Mich. , Jan. 15, 2014 As health ... the flu virus, select Meijer pharmacies in Michigan ... strep throat to eligible patients, enabling Meijer pharmacists to administer ... strict protocol set by a physician participating in the study. ...
    (Date:1/15/2014)... , January 15, 2014 Shire plc (LSE: SHP, ... Office of Fair Trading (OFT) approval condition to the announced tender ... VPHM).   As a result of the waiver, the ... to complete the tender offer on January 24, 2014 following the ...
    (Date:1/15/2014)... is very pleased to announce the appointment of Mr. ... Mark was promoted from his current role of Chief Operating ... in Massachusetts , Mississippi ... 2012 with 20+ years of broad-based operations, sales, engineering and ...
    Breaking Medicine Technology:Meijer Pharmacy Offers Free Flu, Strep Testing as Influenza Cases Rise Across the Midwest 2Meijer Pharmacy Offers Free Flu, Strep Testing as Influenza Cases Rise Across the Midwest 3Shire Waives OFT Condition Relating to the Acquisition of ViroPharma Inc. 2Shire Waives OFT Condition Relating to the Acquisition of ViroPharma Inc. 3Tegra Medical Appoints New Chief Executive Officer 2Tegra Medical Appoints New Chief Executive Officer 3
    ... May 11, 2011 Chimerix, Inc., a pharmaceutical ... showing that the majority of immunocompromised patients with ... lead antiviral compound, CMX001, had a > 99% ... two weeks of therapy.  These CMX001 clinical data, ...
    ... AUSTIN, Texas, May 11, 2011 HCB Health, one ... the nation and the leading healthcare agency in the ... campaign in the 22nd annual Manny Awards, a national ... was presented for a consumer campaign supporting Sound Surgical ...
    Cached Medicine Technology:CMX001 Shows Antiviral Activity in Immunocompromised Transplant Patients With Severe Adenovirus Infection 2CMX001 Shows Antiviral Activity in Immunocompromised Transplant Patients With Severe Adenovirus Infection 3HCB Health Wins Manny Award for Best Medical Device Campaign 2
    (Date:4/18/2014)... Medicine scientists could lead to potential new treatments for ... scleroderma. , Fibrosis, or scarring, is a hallmark ... and lungs can lead to serious organ damage and, ... therapeutic options centers on findings made by Swati Bhattacharyya, ... role that a specific protein plays in promoting fibrosis. ...
    (Date:4/17/2014)... specifically associated with the risk of a difficult-to-diagnose ... of all breast cancer cases. , The largest ... invasive lobular carcinoma, gives researchers important clues to ... breast cancer, which can be missed through screening. ... journal PloS Genetics , was co-led by ...
    (Date:4/17/2014)... study published today in PLOS Pathogens , children ... is common can mount an immune response to infection ... repeated bouts of high fever and illness and partially ... The findings may help researchers develop future interventions that ... parasite. , Each year, approximately 200 million cases of ...
    (Date:4/17/2014)... (April 17, 2014) Two recent papers by ... and colleagues may help scientists develop treatments or ... fever, Japanese encephalitis and other disease-causing flaviviruses. , ... and molecular genetics at the School of Medicine ... Hughes Medical Institute, and colleagues recently published articles ...
    (Date:4/17/2014)... team has created a new technology for modifying ... travel the body and selectively target cancer and ... devices that monitor and modify human physiology is ... no existing technology enabled bioengineers to build such ... respond in a customized fashion. , "The project ...
    Breaking Medicine News(10 mins):Health News:New clues on tissue scarring in scleroderma 2Health News:First genetic link discovered to difficult-to-diagnose breast cancer sub-type 2Health News:First genetic link discovered to difficult-to-diagnose breast cancer sub-type 3Health News:Study sheds light on how the immune system protects children from malaria 2Health News:CU researchers discover target for treating dengue fever 2Health News:Building 'smart' cell-based therapies 2
    ... , ALEXANDRIA, Va., Oct. 7 Catholic Charities USA ... assessment and response team to American Samoa to assist ... coordinate with FEMA and other agencies in providing relief ... of the earthquake and tsunami devastation. , (Logo: ...
    ... Ancient Hamar Tribe Adopts Sustainable Hygiene and Water Programs ... ISLAND, Wash., Oct. 7 Northwest-based nonprofit Global Team ... grant by US Agency for International Development (USAID) to ... in Ethiopia. Since 2008, GTLI, which incubated a ...
    ... PRXL ) will release First Quarter Fiscal Year 2010 financial ... stock market. The announcement will be available on PAREXEL,s website ... website at www.prnewswire.com . , PAREXEL will host ... Wednesday, October 28, 2009 to discuss the results. To access ...
    ... This press release is available in French ... tourism in Latin America needs to be regulated to ... new study published in the journal Developing World ... marketing themselves to international health care consumers: these clinics ...
    ... are helping, but more is needed to stem teen obesity, ... in the United States are becoming healthier places thanks to ... still more is needed to combat teen obesity, a series ... studies, which appear in a September supplement to the ...
    ... The Ensign Group, Inc. (Nasdaq: ENSG ), announced ... facilities, South Valley Care Center in West Jordan, a ... Care Center in Provo, and Castle Country Care Center ... , (Logo: http://www.newscom.com/cgi-bin/prnh/20071213/LATH168LOGO ) , "These strategic ...
    Cached Medicine News:Health News:Catholic Charities USA Moves Disaster Response Team to American Samoa 2Health News:Global Team for Local Initiatives Awarded $387,000 by USAID: New Model for Indigenous Health in Ethiopia 2Health News:PAREXEL Announces Date of First Quarter Fiscal Year 2010 Earnings Release and Conference Call 2Health News:Study examines ethical dilemmas of medical tourism 2Health News:Nutrition Still Not 'A' Grade in U.S. Schools: Studies 2Health News:The Ensign Group Acquires Three Utah Skilled Nursing Facilities 2
    ... system builds on the basic infrastructure ... in the system are networked to ... Windows® operating system, which monitors system ... personal computer, RoamAlert Integrity provides reporting ...
    ... Awarix provides an enterprise visibility ... throughput, improve caregiver effectiveness, and increase ... edge RFID location systems and geospatial ... systems to create a real time ...
    MONOJECT MAGELLAN Safety Blood Collection Needle...
    This is adapted to microplate or card....
    Medicine Products: